OmniAb Investor Presentation Deck

Launching OmniDeep at PEGS- Boston 19TH ANNUAL PEGS BOSTON CONFERENCE & EXPO 1:10 Wrangling Diverse OmniAb Antibody OmniAb Repertoires with OmniDeep Bob Chen, PhD, Sr. Director, Systems Engineering, OmniAb, Inc. We are presenting a showcase of discovering common light chain antibodies against a NK cell target. OmniDeep is a suite of in silico tools for antibody therapeutic discovery and optimization. Deep screening and high-throughput expression/characterization were used to seed information on top of NGS data sets. Our results demonstrate the power of this approach in corralling diverse OmniAb antibody repertoires and accelerating the development of effective therapeutics. OmniDeep OmniDeep is a suite of in silico tools for therapeutic discovery and optimization that are woven throughout OmniAb, Inc.'s various technologies and capabilities. These tools include structural modeling, large multi-species antibody databases, molecular dynamics simulations, Al, and machine and deep learning sequence models, and more. OmniDeep facilitates rapid identification of candidates with the right affinity, specificity, and developability profiles, to make drug development more effective and efficient. 24 OmniAb

View entire presentation